Second-site NMR screening and linker design

被引:47
|
作者
Jahnke, W [1 ]
Flörsheimer, A
Blommers, MJJ
Paris, CG
Heim, J
Nalin, CM
Perez, LB
机构
[1] Novartis Pharma AG, Cent Technol, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Oncol Res, CH-4002 Basel, Switzerland
[3] Novartis Pharma AG, Cent Technol, Summit, NJ 07901 USA
[4] Novartis Pharma AG, Oncol Res, Summit, NJ 07901 USA
关键词
D O I
10.2174/1568026033392778
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
One of the prime merits of NMR as a tool for lead finding in drug discovery research is its sensitivity and robustness to detect weak protein-ligand interactions. This sensitivity allows to build up ligands for a given target in a modular way, by a fragment-based approach. In this approach, two ligands are seperately identified which bind to the target protein generally weakly but at adjacent binding sites. In a next step, they are chemically linked to produce a high-affinity ligand. This review discusses methods to detect "second-site" ligands that bind to a protein in the presence of a "first-site" ligand, and methods to elucidate structural details on the spatial orientation of both ligands, so that chemical linkage is based on a large piece of experimental information. Published examples from second-site screening and linker design are summarized, and are complemented by previously unpublished in-house examples.
引用
收藏
页码:69 / 80
页数:12
相关论文
共 50 条
  • [1] Second-site NMR screening with a spin-labeled first ligand
    Jahnke, Wolfgang
    Perez, Lawrence B.
    Paris, C. Gregory
    Strauss, Andre
    Fendrich, Gabriele
    Nalin, Carlo M.
    1600, ACS, Washington, DC, USA (122):
  • [2] Second-site NMR screening with a spin-labeled first ligand
    Jahnke, W
    Perez, LB
    Paris, CG
    Strauss, A
    Fendrich, G
    Nalin, CM
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (30) : 7394 - 7395
  • [3] Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors
    Vazquez, Jesus
    Tautz, Lutz
    Ryan, Jennifer J.
    Vuori, Kristiina
    Mustelin, Tomas
    Pellecchia, Maurizio
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (09) : 2137 - 2143
  • [4] Multiple ligand docking by Glide: implications for virtual second-site screening
    Márton Vass
    Ákos Tarcsay
    György M. Keserű
    Journal of Computer-Aided Molecular Design, 2012, 26 : 821 - 834
  • [5] Multiple ligand docking by Glide: implications for virtual second-site screening
    Vass, Marton
    Tarcsay, Akos
    Keseru, Gyoergy M.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2012, 26 (07) : 821 - 834
  • [6] The screening of the second-site suppressor mutations of the common p53 mutants
    Otsuka, Kazunori
    Kato, Shunsuke
    Kakudo, Yuichi
    Mashiko, Satsuki
    Shibata, Hiroyuki
    Ishioka, Chikashi
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) : 559 - 566
  • [7] Computational design of second-site suppressor mutations at protein-protein interfaces
    Sammond, Deanne W.
    Eletr, Ziad M.
    Purbeck, Carrie
    Kuhlman, Brian
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2010, 78 (04) : 1055 - 1065
  • [8] A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand
    Qi Sun
    Jason Phan
    Anders R. Friberg
    DeMarco V. Camper
    Edward T. Olejniczak
    Stephen W. Fesik
    Journal of Biomolecular NMR, 2014, 60 : 11 - 14
  • [9] A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand
    Sun, Qi
    Phan, Jason
    Friberg, Anders R.
    Camper, DeMarco V.
    Olejniczak, Edward T.
    Fesik, Stephen W.
    JOURNAL OF BIOMOLECULAR NMR, 2014, 60 (01) : 11 - 14
  • [10] Second-site RecA - DNA interactions: Lack of identical recognition
    Wittung, P
    Bazemore, LR
    Takahashi, M
    Norden, B
    Radding, C
    BIOCHEMISTRY, 1996, 35 (48) : 15349 - 15355